Compare AU

Compare QUS vs. DRUG

Compare shares and ETFs on the ASX that you can trade on Pearler.

Betashares S&P 500 Equal Weight ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Betashares S&P 500 Equal Weight ETF (QUS) and the BetaShares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

QUS

DRUG

Popularity

Low

Low

Pearlers invested

71

61

Median incremental investment

$1,026.29

$920.50

Median investment frequency

Monthly

Monthly

Median total investment

$4,165.70

$1,931.12

Average age group

> 35

26 - 35


Key Summary

QUS

DRUG

Strategy

QUS.AX was created on 2014-12-17 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. QUS.AX aims to track the performance of the S&P 500 Equal Weight Index (before fees and expenses). The Index provides exposure to 500 leading listed U.S. companies, with each holding in the index weighted equally.

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

Top 3 holdings

CONSTELLATION ENERGY CORP (0.27 %)

WALGREENS BOOTS ALLIANCE INC (0.27 %)

BROADCOM INC (0.26 %)

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

Top 3 industries

Industrials (15.47 %)

Financials (14.10 %)

Information Technology (13.41 %)

Other (75.65 %)

Communication Services (33.53 %)

Health Care (24.25 %)

Top 3 countries

United States (98.60 %)

Switzerland (0.39 %)

United Kingdom of Great Britain and Northern Ireland (0.39 %)

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Management fee

0.29 %

0.57 %


Key Summary

QUS

DRUG

Issuer

BetaShares

BetaShares

Tracking index

S&P 500 Equal Weighted

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

Asset class

ETF

ETF

Management fee

0.29 %

0.57 %

Price

$54.31

$8.08

Size

$774.802 million

$183.750 million

10Y return

112.90 %

N/A

Annual distribution yield (5Y)

4.92 %

1.89 %

Market

ASX

ASX

First listed date

19/12/2014

08/08/2016

Purchase fee

$6.50

$6.50


Community Stats

QUS

DRUG

Popularity

Low

Low

Pearlers invested

71

61

Median incremental investment

$1,026.29

$920.50

Median investment frequency

Monthly

Monthly

Median total investment

$4,165.70

$1,931.12

Average age group

> 35

26 - 35


Pros and Cons

QUS

DRUG

Pros

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

QUS

DRUG

Higher exposure to US market

Lower exposure to US market

Lower management fee

Higher management fee

Higher price growth

Lower price growth

Higher distribution yield

Lower distribution yield

Home